Filippos Michopoulos
0000-0002-3667-6147
Publication & Citation Trends
Most Cited Works
Publications
89 total
Identification of a Molecularly-Defined Subset of Breast and Ovarian Cancer Models that Respond to WEE1 or ATR Inhibition, Overcoming PARP Inhibitor Resistance PDF
Cited by 83
OpenAlex
Quantitation of Endogenous Metabolites in Mouse Tumors Using Mass-Spectrometry Imaging
Cited by 74
OpenAlex
Pre-clinical pharmacology of AZD3965, a selective inhibitor of MCT1: DLBCL, NHL and Burkitt’s lymphoma anti-tumor activity PDF
Cited by 151
OpenAlex
Targeted Metabolic Profiling of the Tg197 Mouse Model Reveals Itaconic Acid as a Marker of Rheumatoid Arthritis
Cited by 45
OpenAlex
Inhibition of Monocarboxylate Transporter-1 (MCT1) by AZD3965 Enhances Radiosensitivity by Reducing Lactate Transport PDF
Cited by 188
OpenAlex
Targeted profiling of polar intracellular metabolites using ion-pair-high performance liquid chromatography and -ultra high performance liquid chromatography coupled to tandem mass spectrometry: Applications to serum, urine and tissue extracts
Cited by 91
OpenAlex
Research Topics
Metabolomics and Mass Spectrometry Studies
(29)
Cancer, Hypoxia, and Metabolism
(24)
Analytical Chemistry and Chromatography
(15)
CRISPR and Genetic Engineering
(12)
PI3K/AKT/mTOR signaling in cancer
(11)
Frequent Co-Authors
Affiliations
AstraZeneca (United Kingdom)
University of Southern California
Leiden University
University of Macedonia
Aristotle University of Thessaloniki